186 related articles for article (PubMed ID: 17955101)
1. Refractory Clostridium difficile-associated diarrhea.
Grover S; Hamilton MJ; Carr-Locke DL
MedGenMed; 2007 May; 9(2):46. PubMed ID: 17955101
[No Abstract] [Full Text] [Related]
2. In vivo selection of moxifloxacin-resistant Clostridium difficile.
Mena A; Riera E; López-Causapé C; Weber I; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2012 May; 56(5):2788-9. PubMed ID: 22371889
[No Abstract] [Full Text] [Related]
3. Challenges in the diagnosis of Clostridium difficile infection.
Corsello PM; Micic D; Rao K; Waljee AK
Gastroenterology; 2014 Jun; 146(7):1820-2. PubMed ID: 24768590
[No Abstract] [Full Text] [Related]
4. In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.
Carman RJ; Boone JH; Grover H; Wickham KN; Chen L
Antimicrob Agents Chemother; 2012 Nov; 56(11):6019-20. PubMed ID: 22908175
[TBL] [Abstract][Full Text] [Related]
5. Future novel therapeutic agents for Clostridium difficile infection.
Koo HL; Garey KW; Dupont HL
Expert Opin Investig Drugs; 2010 Jul; 19(7):825-36. PubMed ID: 20521993
[TBL] [Abstract][Full Text] [Related]
6. Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations.
Mathur H; O'Connor PM; Hill C; Cotter PD; Ross RP
Antimicrob Agents Chemother; 2013 Jun; 57(6):2882-6. PubMed ID: 23571539
[TBL] [Abstract][Full Text] [Related]
7. A case of Clostridium difficile bacteremia in a patient with loop ileostomy.
Choi JL; Kim BR; Kim JE; Woo KS; Kim KH; Kim JM; Lee SE; Han JY
Ann Lab Med; 2013 May; 33(3):200-2. PubMed ID: 23667848
[TBL] [Abstract][Full Text] [Related]
8. Laboratory diagnosis of Clostridium difficile infection.
Goldenberg SD; Cliff PR; French GL
J Clin Microbiol; 2010 Aug; 48(8):3048-9. PubMed ID: 20668301
[No Abstract] [Full Text] [Related]
9. Clostridium difficile bacteremia, Taiwan.
Lee NY; Huang YT; Hsueh PR; Ko WC
Emerg Infect Dis; 2010 Aug; 16(8):1204-10. PubMed ID: 20678312
[TBL] [Abstract][Full Text] [Related]
10. The insect peptide coprisin prevents Clostridium difficile-mediated acute inflammation and mucosal damage through selective antimicrobial activity.
Kang JK; Hwang JS; Nam HJ; Ahn KJ; Seok H; Kim SK; Yun EY; Pothoulakis C; Lamont JT; Kim H
Antimicrob Agents Chemother; 2011 Oct; 55(10):4850-7. PubMed ID: 21807975
[TBL] [Abstract][Full Text] [Related]
11. [Clostridium difficile associated diarrhea: reliable therapy with vancomycin capsules].
MMW Fortschr Med; 2012 Sep; 154(16):64-5. PubMed ID: 23045940
[No Abstract] [Full Text] [Related]
12. A possible role for Clostridium difficile in the etiology of calf enteritis.
Hammitt MC; Bueschel DM; Keel MK; Glock RD; Cuneo P; DeYoung DW; Reggiardo C; Trinh HT; Songer JG
Vet Microbiol; 2008 Mar; 127(3-4):343-52. PubMed ID: 17964088
[TBL] [Abstract][Full Text] [Related]
13. Treating Clostridium difficile infection.
Shafran DM; Shafran SD
CMAJ; 2014 Apr; 186(7):531. PubMed ID: 24344151
[No Abstract] [Full Text] [Related]
14. Clostridium difficile drug pipeline: challenges in discovery and development of new agents.
Jarrad AM; Karoli T; Blaskovich MA; Lyras D; Cooper MA
J Med Chem; 2015 Jul; 58(13):5164-85. PubMed ID: 25760275
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile colitis.
Kelly CP; Pothoulakis C; LaMont JT
N Engl J Med; 1994 Jan; 330(4):257-62. PubMed ID: 8043060
[No Abstract] [Full Text] [Related]
16. Clostridium difficile infection: new developments in epidemiology and pathogenesis.
Rupnik M; Wilcox MH; Gerding DN
Nat Rev Microbiol; 2009 Jul; 7(7):526-36. PubMed ID: 19528959
[TBL] [Abstract][Full Text] [Related]
17. Continuous Administration of Vancomycin through a Long Intestinal Tube for Clostridium difficile Infection.
Mizumura N; Demura K; Kawasaki M; Okumura S; Toyoda S; Imagawa A; Ogawa M; Ohba K; Kameyama M
Intern Med; 2015; 54(12):1559-62. PubMed ID: 26073250
[TBL] [Abstract][Full Text] [Related]
18. Relationship between antibiotic consumption and Clostridium difficile-associated diarrhea: an epidemiological note.
Kaier K; Frank U
Antimicrob Agents Chemother; 2009 Oct; 53(10):4574-5. PubMed ID: 19770290
[No Abstract] [Full Text] [Related]
19. Bezlotoxumab (Zinplava) for prevention of recurrent Clostridium difficile infection.
Med Lett Drugs Ther; 2017 Mar; 59(1517):49-50. PubMed ID: 28323808
[No Abstract] [Full Text] [Related]
20. Hidradenitis suppurativa and risk for development of Clostridium difficile colitis.
Lyons AB; Kaddurah H; Peacock A; Zubair R; Vellaichamy G; Norwick P; Ramesh M; Jacobsen G; Hamzavi IH
Int J Dermatol; 2020 Jun; 59(6):e218-e219. PubMed ID: 32010962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
